Literature DB >> 3943536

Tetanus toxin receptors on nerve cells contain a trypsin-sensitive component.

E Yavin, A Nathan.   

Abstract

Cerebral neurons in monolayer cultures, subjected to 25 micrograms/ml trypsin, lose after 10 min about 43.5% and 40.5% of the ability to bind 125I-labeled tetanotoxin as measured at 0-4 degrees C and 37 degrees C respectively. These losses are maximal by 30 min and can be prevented by 1.5 mg/ml soybean trypsin inhibitor. Chymotrypsin but not collagenase or hyaluronidase is also effective in reducing binding of toxin to cells. The trypsin-insensitive toxin-binding activity can be further eliminated by treatment with sialidase or by cell extraction with methanol. Fixation of cells with 3.5% paraformaldehyde or 2% glutaraldehyde also results in a marked decrease of 52.4% and 25% respectively in the toxin-cell association. Methanol or sialidase but not trypsin removes the remaining binding activity. About one-third of the lipid-linked and protein-linked sialic acid is removed after sialidase treatment whereas 1% and 9.4% respectively are removed after trypsin treatment. The data are consistent with the possibility that, in addition to a sialic acid component, binding of tetanotoxin to nerve cells is facilitated by a trypsin-removable and formaldehyde-inactivated component. There was no evidence for a polypeptide to substitute gangliosides as receptors for tetanotoxin. On the contrary, solubility in organic solvents and interaction of the extracted products with labeled toxin remain the major proof that gangliosides are the putative receptors for tetanotoxin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3943536     DOI: 10.1111/j.1432-1033.1986.tb09412.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

1.  C-terminal half of tetanus toxin fragment C is sufficient for neuronal binding and interaction with a putative protein receptor.

Authors:  J Herreros; G Lalli; G Schiavo
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

Review 2.  The Molecular Basis of Toxins' Interactions with Intracellular Signaling via Discrete Portals.

Authors:  Adi Lahiani; Ephraim Yavin; Philip Lazarovici
Journal:  Toxins (Basel)       Date:  2017-03-16       Impact factor: 4.546

3.  Lipid rafts act as specialized domains for tetanus toxin binding and internalization into neurons.

Authors:  J Herreros; T Ng; G Schiavo
Journal:  Mol Biol Cell       Date:  2001-10       Impact factor: 4.138

4.  HC fragment (C-terminal portion of the heavy chain) of tetanus toxin activates protein kinase C isoforms and phosphoproteins involved in signal transduction.

Authors:  C Gil; I Chaib-Oukadour; J Blasi; J Aguilera
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

5.  C-terminal fragment of tetanus toxin heavy chain activates Akt and MEK/ERK signalling pathways in a Trk receptor-dependent manner in cultured cortical neurons.

Authors:  Carles Gil; Imane Chaib-Oukadour; José Aguilera
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

6.  SV2 mediates entry of tetanus neurotoxin into central neurons.

Authors:  Felix L Yeh; Min Dong; Jun Yao; William H Tepp; Guangyun Lin; Eric A Johnson; Edwin R Chapman
Journal:  PLoS Pathog       Date:  2010-11-24       Impact factor: 6.823

7.  Interaction of botulinum and tetanus toxins with the lipid bilayer surface.

Authors:  C Montecucco; G Schiavo; Z Gao; E Bauerlein; P Boquet; B R DasGupta
Journal:  Biochem J       Date:  1988-04-15       Impact factor: 3.857

Review 8.  Tetanus and botulinum neurotoxins: mechanism of action and therapeutic uses.

Authors:  R Pellizzari; O Rossetto; G Schiavo; C Montecucco
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-02-28       Impact factor: 6.237

9.  Neurotrophic Properties of C-Terminal Domain of the Heavy Chain of Tetanus Toxin on Motor Neuron Disease.

Authors:  Mireia Herrando-Grabulosa; Caty Casas; Kevin Talbot; José Aguilera
Journal:  Toxins (Basel)       Date:  2020-10-21       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.